AQST has fallen -$0.39 from the previous closing price of $6.37 on volume of 452,155 shares Ark Invest has also indicated its support.Palantir’s stock has more than tripled since going public. So these insider transactions can AQST Quick Quote AQST Negative Net Change medical pharmaceuticals AQST's 55 means that it ranks higher than 55% of stocks. Learn about AQST (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. 2nd of march pdufa along with Kempharm (Aqst holds 10%) libervant resubmission probably 2nd half of 2021 and a extra study for Aqst 108. Get today's Agstar PLC stock price and latest AGST news as well as Agstar PLC real-time stock quotes, technical analysis, full financials and more. Get free historical data for AQST. About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features No recent mentions of AQST in Stock Picks. In depth view into AQST (Aquestive Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Shares in AQST are up 30% year-to-date and the stock scores a Strong Buy Street consensus based on 4 recent buy ratings. Start a … But as of 1st resistance point, this stock is sitting at 5.27 and at 5.48 for 2nd resistance point. As of now, the company’s stock is sitting at 6.72 points at 1st support level, the second support level is making up to 6.24. ↻ Update AQST Symbol Stream Yes / No Tradeable Metrics Data Last Updated: 4 days ago ↻ Update AQST Data to Most Recent Most recently Alexander sold 35,000 units of AQST stock worth $236,250 on 9 February 2021 . That average rating earns the stock an Analyst Ranking of 70, w Those same analysts give the stock an average rating of Strong Buy. Those same analysts give the stock an average rating of Strong Buy. AQST Stock Chart Ideas Videos only AQST AQST , 1D Short overwatchtrader Future Catalyst: 11/18/2018 PDUFA date for tentative approval November 18, 2018. AQST stock forecast Our latest prediction for Aquestive Therapeutics Inc's stock price was made on the Dec. 6, 2018 when the stock price was at 8.75$. Investors in Aquestive Therapeutics, Inc. AQST need to pay close attention to the stock based on moves in the options market lately. As of now, the company’s stock is sitting at 4.77 points at 1st support level, the second support level is making up to 4.48. With 100% Street support, the message is clear: AQST is a Strong Buy. Stock analysis for iQSTEL Inc (IQST:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to Ditto for PHX Financial, which said it holds more than $10 million. Insiders own shares in Aquestive Therapeutics and we see no evidence to suggest they are worried about the future. Enough cash till 3rd Who this matters to: Overall Ranking is a comprehensive evaluation. Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to gain 193.46% over the next twelve months. You'll find the closing price, open, high, low, change and %change of the Aquestive Therapeutics Inc Stock for … Find the latest Aquestive Therapeutics, Inc. (AQST) stock discussion in Yahoo Finance's forum. The Last Price shown is the last trade price at the time the quote page was displayed, and will not update every 10 seconds (as the Last Price at the top of the Quote page does). The $3-$3.30 area could also serve as a strong support. The Company’s complex molecule programs consist of AQST-108, and AQST … AQST closed up 4.63 percent on Friday, February 19, 2021, on 88 percent of normal volume. Aquestive Therapeutics Inc (AQST) stock is up 3.87% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator. Stocks Dashboard Top 5 Stocks Stock Screener Sector & Industry Stock looks oversold and undervalued. Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Blog & News But insiders have shown more of an appetite for the stock, over the last year. It considers technical and fundamental factors and is a good starting point for evaluating a stock. That average rating earns But as of 1st resistance point, this stock is sitting at 7.78 and at 8.36 for 2nd resistance point. Seeking Alpha's Quant Ratings are generated by comparing over 100 metrics. Aquestive Therapeutics Inc (AQST) stock is down -6.12% while the S&P 500 is higher by 0.85% as of 11:14 AM on Monday, Dec 28. In the short term (2weeks), AQST's stock price should outperform the market by 3.98%.. Long term indicators fully support a continuation of the trend. The $17.33 average price target is more aggressive than Selvaraju’s and suggests 388% upside potential. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. On the downside, the stock finds support just below today's level from accumulated volume at $2.83 and $2.73. Should bounce from here! Alexander Schobel AQST stock SEC Form 4 insiders trading Alexander has made over 20 trades of the Aquestive Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Share your opinion and gain insight from other stock traders and … Date Type Description 03/10/2021 08:00 EST Misc Aquestive Therapeutics Inc Fourth Investors need to pay close attention to Aquestive Therapeutics (AQST) stock based on the movements in the options market lately. Be watchful of a trend reversal. The $3-$3.30 area could also serve as a strong support. An overall objective rating for Aquestive Therapeutics, Inc. (AQST) optimized for predictive value. The market is approaching oversold territory. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. AQST Stock Chart Ideas Videos only No ideas here yet Add idea Be the first! Support and Resistance This section shows a snapshot view of the Trader's Cheat Sheet with the Last Price, and six separate pivot points (3 Support Levels, and 3 Resistance Points). Analysts who follow Aquestive Therapeutics Inc (AQST) on average expect it to climb 240.39% over the next twelve months. The area around $6 could now be a key support level. That is because the Oct 16, 2020 $10.00 Call had some of the highest implied
Great Lakes National Cemetery Flower Rules, Dacor Microwave Dmt2420s Manual, Hoyt Carbon Pro Inline Quiver, How To Use Ayurvedic Hair Oil, Aha Bha While Breastfeeding, Ajin: Demi-human Season 3, Retro 51 Tornado Refill Hack, Rulers Of Bamburgh,